Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications

Gene Therapy

Volumn 5, Issue 11, 1998, Pages 1517-1530

  Krisky, D M ^a   Marconi, P C ^a   Oligino, T J ^a   Rouse, R J D ^a   Fink, D J ^a   Cohen, J B ^a   Watkins, S C ^a   Glorioso, J C ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Herpes simplex virus; Multigene vectors

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS VECTOR;

ARTICLE; CYTOTOXICITY; DNA SEQUENCE; GENE CASSETTE; GENE DELETION; GENE THERAPY; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; MELANOMA CELL; NONHUMAN; PRIORITY JOURNAL; TRANSGENE; VIRUS REPLICATION;

DNA VIRUSES; HERPES; HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 0031794565     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300755     Document Type: Article

References (60)

1. Roizman B, Sears A. Herpes simplex viruses and their replication. In: Fields BN et al (eds). Fields Virology, 3rd edn. Lippincott-Raven: Philadelphia, 1996, pp 2231-2295.
2. Honess R, Roizman B. Regulation of herpes simplex virus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J Virol 1974; 14: 8-19.
3. Campbell MEM, Palfeyman JW, Preston CM. Identification of herpes simplex virus DMA sequences which encode a trans-acting polvpeptide responsible for stimulation of immediate-early transcription. J Mol Biol 1984; 180: 1-19.
4. Mackem S, Roizman B. Differentiation between alpha promoter and regulatory regions of herpes simplex virus type 1: the functional domains and sequence of a movable alpha regulator. Proc Natl Acaci Sci USA 1982; 79: 4917-4921.
5. Preston C, Frame M, Campbell M. A complex formed between cell components and an HSV structural polypeptide binds to a viral immediate-early gene regulatory DNA sequence. Cell 1988; 52: 425-454.
6. DeLuca NA, McCarthy AM, Schaffer PA. Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J Vtrol 1985; 56: 558-570.
7. Dixon RAF, Schaffer PA. Fine-structure mapping and functional analysis of temperature-sensitive mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein VP175. J Viral 1980; 36: 189-203.
8. McCarthy AM, McMahan L, Schaffer PA. Herpes simplex virus type 1 ICP27 deletion mutants exhibit altered patterns of transcription and are DNA deficient. J Virol 1989; 63: 18-27.
9. Preston C. Abnormal properties of an immediate-early polypeptide in cells infected with the herpes simplex virus type 1 mutant tsK. J Virol 1979; 32: 357-369,
10. Sacks W, Greene C, Aschman D, Schaffer P. Herpes simplex virus type l ICP27 is essential regulatory protein. J Virol 1985; 55: 796-805.
11. Watson R, Clements J. A herpes simplex virus type 1 function continuously required for early and late virus RNA synthesis. Nature 1980; 285: 329-330.
12. Rice S, Long M, Lam V, Spencer C. RNA polymerase II is aberrantly phosphorylated and localized to viral replication compartments following herpes simplex virus infection. J Virol 1994; 68: 988-1001.
13. Sacks WR, Schaffer PA. Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICPO exhibit impaired growth in cell culture. J Virol 1987; 61: 829-839.
14. Stow N, Stow E. Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate-early polypeptide Vmw 110. J Gen Virol 1986; 67: 2571-2585.
15. Everett RD. Transactivation of transcription by herpes simplex virus products: requirements for two herpes simplex virus type 1 immediate-early polypeptides for maximum activity, EMBO J 1984; 3: 3135-3141.
16. Gelman IH, Silverstein S. Identification of immediate-early genes from herpes simplex virus that transactivate the virus thymidine kinase gene. Proc Natl Acad Sci USA 1985; 82: 5265-5269.
17. Carter KL, Roizman B. Alternatively spliced mRNAs predicted to yield frame-shift proteins and stable intion 1 RNAs of the herpes simplex virus 1 regulatory gene alpha 0 accumulate in the cytoplasm of infected cells. Proc Natl Acad Sci USA 1996; 93: 12535-12540.
18. Purves FC, Ogle WO, Roizman B. Processing of the herpes simplex virus regulatory protein a 22 mediated by the UL13 protein kinase determines the accumulation of a subset of α and γ mRNAs and proteins in infected cells. Proc Natl Acad Sci USA 1993; 90: 6701-6705.
19. Fruh K et al. A viral inhibitor of peptide transporters for antigen presentation. Nature 1995; 375: 415-418.
20. Hill A et al. Herpes simplex virus turns off the TAP to evade host immunity. Nature 1995; 375: 411-415.
21. Hill A, Ploegh H. Getting the inside out: the transporter associated with antigen processing (TAP) and the presentation of viral antigen. Proc Natl Acad Sci USA 1995, 92: 341-343.
22. + T lymphocytes. Cell 1994; 77: 525-535.
23. Johnson P et al. Cytotoxicity of a replication-defective mutant herpes simplex virus type 1 . J Virol 1992; 66: 2952-2965.
24. Marconi P et al. Replication-defective HSV vectors for gene transfer in vivo. Proc Natl Acad Sci USA 1996; 93:11319-11320.
25. Samaniego L, Webb A, DeLuca N. Functional interaction between herpes simplex virus immediate-early proteins during infection: gene expression as a consequence of ICP27 and different domains of ICP4. J Virol 1995; 69: 5705-5715.
26. Samaniego L, Naxin W, DeLuca N. The herpes simplex virus immediate-early protein 1CP0 affects transcription from the viral genome and infected-cell survival in the absence of ICP4 and ICP27. J Virol 1997; 71: 4614-4625.
27. Wu N, Watkins SC, Schaffer PA, DeLuca NA. Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22. J Virol 1996; 70: 6358-6368.
28. Carter K, Roizman B. The promoter and transcriptional unit of a novel herpes simplex virus 1 alpha gene are contained in, and encode a protein in frame with, the open reading frame of the alpha22 gene. J Virol 1996; 70: 172-178.
29. Summers WP, Wagner M, Summers WC. Possible peptide chain termination mutants in thymidine kinase gene of a mammalian virus, herpes simplex virus. Proc Natl Acad Sci USA 1975; 72: 4081-1084.
30. Chung T et al. Protein kinase activity associated with the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICPO). J Virol 1989; 63: 3389-3398.
31. Preston VG, Palfreyman JW, Dutia BM. Identification of a herpes simplex virus type 1 polypeptide which is a component of the virus-induced ribonucleotide reductase. J Gen Virol 1984; 65: 1457-1466.
32. Kwong AD, Kruper JA, Frenkel N. Herpes simplex virus virion host shutoff function. J Virol 1988; 62: 912-921.
33. Oroskar A, Read G. Control of mRNA stability by the virion host shutoff function of herpes simplex virus. J Virol 1989; 63: 1897-1906.
34. Read GS, Frenkel N. Herpes simplex virus mutants defective in the virion-associated shutoff of host polypeptide synthesis and exhibiting abnormal synthesis of α (immediate-early) viral polypeptides. J Virol 1983; 46: 498-512.
35. Chen L et al. Costimulation of antitumor immunity by the B7 counter-receptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 1992; 71: 1093-1102.
36. Freeman SM et al. The 'bystander effect' : tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 1993; 53: 5274-5283.
37. Moolten FL. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 1986; 46: 5276-5281.
38. Krisky D et al. Rapid method for construction of recombinant HSV gene transfer vectors. Gene Therapy 1997; 4: 1120-1125.
39. DeLuca NA, Schaffer PA. Activation of immediate-early, early, and late promoters by temperature-sensitive and wild-type forms of herpes simplex virus type 1 protein ICP4. Mol Cell Biol 1985; 5: 1997-2008.
40. Fuller AO, Lee WC. Herpes simplex virus type 1 entry through a cascade of virus-cell interactions requires different roles of gD and gH in penetration J Virol 1992; 66: 5002-5012.
41. Herold B et al. Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulfate and glycoprotein B. J Gen Virol 1994; 75: 1211-1222.
42. Spear PG et al. Heparan sulfate glycosaminoglycans as primary cell surface receptors for herpes simplex virus. Adv Exp Med Biol 1992; 313: 341-353.
43. Holland TC, Marlin SD, Levine M, Glorioso JC. Antigenic varients of herpes simplex virus selected with glycoprotein-specific monoclonal antibodies. J Virol 1983; 45: 672-682.
44. Marlin SD, Holland TC, Levine M, Glorioso JC. Epitopes of herpes simplex virus type 1 glycoprotein gC are clustered in two distinct antigenic sites. J Virol 1985; 53: 128-136.
45. Armentano D et al. Effect of the E4 region on the persistence of transgene expression from adenovirus vectors. J Virol 1997; 71: 2408-2416.
46. Brough DE et al. Activation of transgene expression by early region 4 is responsible for a high level of persistent transgene expression from adenovirus vectors in viva. J Virol 1997; 71: 9206-9213.
47. Kaplan J et al. Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lung. Hum Gene Ther 1997; 8: 45-56.
48. Batterson W, Roizman B. Characterization of the herpes simplex virion-assoaated factor responsible for the induction of alphagenes. J Virol 1983; 46: 371-377.
49. Kristie T, Sharp P. Purification of the cellular Cl factor required for the stable recognition of the Oct-1 homeodomain by herpes simplex virus α-trans-mduction factor (VP16). J Biol Chem 1993; 268: 6525-6534.
50. Werstuck G, Capone J. An unusual cellular factor potentiates protein-DNA complex assembly Oct-1 and Vmw65. J Biol Chem 1993; 268: 1272-1278.
51. Gruenheid S, Gatzke L, Meadows H, Tufaro F. Herpes simplex virus infection and propagation in a mouse L cell mutant lacking heparan sulfate proteoglycans. J Virol 1993; 67: 93-100.
52. Laquerre S et al. Heparan sulfate proteoglycan binding by herpes simplex virus type l glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread. J Virol 1998, 72: 6119-6130.
53. Rasty S, Poliani P, Fink D, Glorioso J. Deletion of the S component inverted repeat sequence c' and the nonessential genes Us1 through Us5 from the herpes simplex virus type 1 genome substantially impairs productive viral infection in cell culture and pathogenesis in the rat central nervous system. J Neurovirol 1997; 3: 247-264.
54. L flanking repeats. J Virol 1994; 68: 2239-2252.
55. Ho DY, Mocarski ES. Herpes simplex virus latent RNA (LAT) is not required for latent infection in the mouse. Pros Nat! Acad Sci USA 1989; 86: 7596-7600.
56. Lachmann RH, Efstathiou S. Utilization of the herpes simplex virus type 1 latency-associated regulatory region to drive stable reporter gene expression in the nervous system. J Virol 1997; 71: 3197-3207.
57. Lokensgard JR, Feldman LT, Berthomme H. The latency-associated promoter of herpes simplex virus type 1 requires a region downstream of the transcription start site for long-term expression during latency. J Virol 1997; 71: 6714-6719.
58. McGeoch DJ, Dolan A, Donald S, Rixon FJ. Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1. J Mol Biol 1985; 181: 1-13.
59. McGeoch DJ, Dolan A, Donald S, Brauer DHK. Complete DNA sequence of short repeat region in the genome of herpes simplex virus type 1. Nucleic Acids Res 1986; 14: 1727-1744.
60. McGeoch DJ et al. The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J Gen Virol 1988; 69: 1531-1574.